AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 112 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $929,681 | +124.0% | 62,186 | +23.3% | 0.00% | – |
Q3 2022 | $415,000 | +21.3% | 50,441 | -3.3% | 0.00% | – |
Q2 2022 | $342,000 | +14.0% | 52,146 | -2.6% | 0.00% | – |
Q1 2022 | $300,000 | +12.4% | 53,547 | -6.0% | 0.00% | – |
Q4 2021 | $267,000 | -27.2% | 56,944 | -3.8% | 0.00% | – |
Q3 2021 | $367,000 | -0.5% | 59,181 | +5.7% | 0.00% | – |
Q2 2021 | $369,000 | -78.0% | 55,993 | -75.5% | 0.00% | – |
Q1 2021 | $1,675,000 | +19.6% | 228,786 | -5.8% | 0.00% | – |
Q4 2020 | $1,401,000 | +3.3% | 242,839 | +6.3% | 0.00% | – |
Q3 2020 | $1,356,000 | +63.4% | 228,369 | +41.7% | 0.00% | – |
Q2 2020 | $830,000 | +822.2% | 161,217 | +548.3% | 0.00% | – |
Q1 2020 | $90,000 | – | 24,869 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |